On October 13, Humana fell 3.61% in Regular Trading, trading at $418.31 per share, with turnover of $177 million.

The clearest recent catalyst was Humana’s announcement that it formed a new strategic joint venture with funds managed by BlackRock’s HPS Investment Partners to operate nearly 150 CenterWell Senior Primary Care clinics, while BlackRock would acquire the prior partner’s stake and become the controlling owner.

Under the agreement, CenterWell will retain a minority stake and continue running day-to-day clinic operations. The venture also plans to deploy additional capital over the next two years to support clinical operations, open new clinics, and pursue strategic acquisitions. While the transaction strengthens capital support for Humana’s senior care delivery network, the stock still moved lower in the session. Separately, Mizuho raised its price target on Humana to $495 from $468, providing supportive backdrop but not preventing the decline.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)